Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Asset Utilization Ratio (2016 - 2025)

Cytokinetics (CYTK) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.11 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.11 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.11, a N/A change, with the full-year FY2023 number at 0.01, down 91.97% from a year prior.
  • Asset Utilization Ratio was 0.11 for Q4 2025 at Cytokinetics, up from 0.05 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.17 in Q2 2022 to a low of 0.01 in Q2 2024.
  • A 5-year average of 0.05 and a median of 0.05 in 2025 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 4398.83% in 2022, then plummeted 258.8% in 2025.
  • Cytokinetics' Asset Utilization Ratio stood at 0.07 in 2021, then surged by 37.53% to 0.09 in 2022, then crashed by 89.36% to 0.01 in 2023, then tumbled by 168.54% to 0.01 in 2024, then skyrocketed by 1761.41% to 0.11 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Asset Utilization Ratio are 0.11 (Q4 2025), 0.05 (Q3 2025), and 0.05 (Q2 2025).